Core Scientific
CORZ
387 hedge funds and large institutions have $5.42B invested in Core Scientific in 2026 Q1 according to their latest regulatory filings, with 77 funds opening new positions, 128 increasing their positions, 118 reducing their positions, and 50 closing their positions.
84% more call options, than puts
Call options by funds: $1.29B | Put options by funds: $702M
54% more first-time investments, than exits
New positions opened: 77 | Existing positions closed: 50
7% more funds holding in top 10
Funds holding in top 10: 27 → 29 (+2)
6% more capital invested
Capital invested by funds: $5.13B → $5.42B (+$284M)
5% more funds holding
Funds holding: 367 → 387 (+20)
1.25% more ownership
Funds ownership: 113.66% → 114.91% (+1.3%)
8% more repeat investments, than reductions
Existing positions increased: 128 | Existing positions reduced: 118
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$97.5M |
| 2 |
Two Sigma Investments
New York
|
+$71.4M |
| 3 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
+$68.2M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$66M |
| 5 |
CC
Clearline Capital
New York
|
+$58.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$71.6M |
| 2 |
Jane Street
New York
|
-$56.3M |
| 3 |
SA
Situational Awareness
San Francisco,
California
|
-$46.9M |
| 4 |
TI
Think Investments
San Francisco,
California
|
-$40.8M |
| 5 |
CC
Covalis Capital
London,
United Kingdom
|
-$31.9M |
CORZ Hedge Fund Activity: Q1 2026 in Review
387 of the 8,187 institutional investors tracked by Wall St. Rank reported a position in Core Scientific (CORZ) for Q1 2026, worth a combined $5.42B — up 5.5% from $5.13B a quarter earlier.
Buyers outnumbered sellers: 77 funds opened new CORZ positions and 50 closed out — a net gain of 27 holders — while 128 added to existing stakes and 118 trimmed.
The largest buyer was UBS Group, adding an estimated $97.5M. The largest seller was Citadel Advisors, cutting an estimated $71.6M.
- 387 institutional investors held Core Scientific (CORZ) as of Q1 2026, up from 367 in Q4 2025.
- Funds reported $5.42B of Core Scientific stock for Q1 2026, up 5.5% quarter-over-quarter.
- 77 funds opened new Core Scientific positions in Q1 2026 and 50 closed out, a net change of +27 holders.
- The largest Core Scientific buyer in Q1 2026 was UBS Group, an estimated $97.5M added.
- The largest Core Scientific seller in Q1 2026 was Citadel Advisors, an estimated $71.6M sold.
Based on aggregated 13F filings for Q1 2026.